Wilson Sonsini Goodrich & Rosati advised Borealis Biosciences on the transaction. Borealis Biosciences (Borealis), a next-generation RNA medicines company, emerged from stealth with $150 million in...
You must be a Standard 1 Year member to access this content.
Skadden, Arps, Slate, Meagher & Flom LLP and Roschier advised Nokia on the transaction, and Wilson Sonsini Goodrich & Rosati advised Infinera. Nokia (NYSE: NOK) and...
You must be a Standard 1 Year member to access this content.
Sidley Austin is advising Clearlake on the transaction, and Willkie Farr & Gallagher is advising Insight, while Wilson Sonsini Goodrich & Rosati and Fenwick & West...
You must be a Standard 1 Year member to access this content.
O’Melveny advised SK Innovation on the deal while Wilson Sonsini represented Amogy. SK Innovation announced its investment in Amogy Inc., a pioneer of ammonia power solutions. The...
You must be a Standard 1 Year member to access this content.
